{"id":2747,"date":"2025-07-07T06:45:20","date_gmt":"2025-07-07T01:15:20","guid":{"rendered":"https:\/\/www.cscr.res.in\/symposium\/?page_id=2747"},"modified":"2025-07-07T06:45:20","modified_gmt":"2025-07-07T01:15:20","slug":"scientific-programme-2024","status":"publish","type":"page","link":"https:\/\/www.cscr.res.in\/symposium\/index.php\/scientific-programme-2024\/","title":{"rendered":"Scientific Programme 2024"},"content":{"rendered":"

9TH<\/sup> ANNUAL SYMPOSIUM ON CELL AND GENE THERAPY<\/span><\/h2>\n

1st<\/sup> \u00a0to 3rd<\/sup>\u00a0 August, 2024<\/span><\/h2>\n

PROGRAMME SCHEDULE <\/span><\/h2>\n

DAY-1: Thursday, 1st<\/sup> \u00a0August, 2024<\/span><\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
1:00 to 1:05 PM<\/p>\n

1:05 to 1:20 PM<\/p>\n

1:20 to 1:25 PM<\/p>\n

1:25 to 1:30 PM<\/td>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Prayer by Chaplain<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Welcome remarks: <\/strong>Director, CMC \/ Director, InStem \/ Principal, CMC<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Remarks by\u00a0 Secretary, Department of Biotechnology, Ministry of Science and Technology, Govt. of India<\/p>\n

\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Closing remarks: <\/strong>Head, CSCR<\/td>\n<\/tr>\n

Session-1:\u00a0 Orthobiologics In Cartilage Repair<\/strong><\/p>\n

Chair: <\/strong>Samuel Chittaranjan<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
1.30 to 2:00 PM<\/td>\nCell-Based Therapeutics for Arthritic Disease<\/td>\nFrank Barry<\/strong><\/p>\n

University of Galway, Ireland<\/td>\n<\/tr>\n

2:00 to 2:30 PM<\/td>\nPRP for OA Knee: Bench to bedside<\/td>\nSandeep Patel<\/strong><\/p>\n

The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India<\/td>\n<\/tr>\n

2:30 to 3:00 PM<\/td>\nThe Role of Extracellular Vesicles and Orthobiologics Secretome in Joint Preservation<\/td>\nElizabeth Vinod<\/strong><\/p>\n

Centre for Stem Cell Research (A unit of inStem, Bengaluru) and CMC, Vellore, India<\/td>\n<\/tr>\n

3:00 to 3:30 PM<\/td>\nPoster presentation<\/strong> and <\/strong>Industry <\/strong>Exhibition<\/strong><\/td>\n<\/tr>\n
Session-<\/strong>2<\/strong>: MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY<\/strong><\/p>\n

Chair: <\/strong>Cartikeya Reddy<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
3:30 to 4:00 PM<\/td>\nChallenges and Promise of CAR-based therapies in India<\/td>\nAkhil Kumar<\/strong><\/p>\n

Aurigene Oncology Limited, Bangalore, India<\/p>\n

and<\/u><\/em><\/strong><\/p>\n

Priyadarshini<\/strong> Chatterjee<\/strong><\/p>\n

Aurigene Oncology Limited, Bangalore, India<\/td>\n<\/tr>\n

4:00 to 4:30 PM<\/td>\nFrom Innovation to Translation to Patients: The Future of Genetically Engineered T-Cells for Human Therapeutics<\/td>\nBruce L. Levine<\/strong><\/p>\n

The University of Pennsylvania,<\/p>\n

Philadelphia, US<\/td>\n<\/tr>\n

4:30 to 5:00 PM<\/td>\nMesenchymal stromal cells for clinical applications: CMC Challenges and Paths Forward<\/td>\nSowmya Viswanathan<\/strong><\/p>\n

Schroeder Arthritis Institute, University Health Network and the University of Toronto, Ontario, Canada<\/td>\n<\/tr>\n

5:00 to 5:15 PM<\/td>\nBreak<\/strong><\/td>\n<\/tr>\n
Session-<\/strong>3<\/strong>: TECHNOLOGY ADVANCES<\/strong><\/p>\n

Chair: Soniya Nityanand<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
5:15 to 5:45 PM<\/td>\nDevelopment of targeted viral platform for selective gene transfer to human HSCs in vivo<\/td>\nDmitry M. Shayakhmetov<\/strong><\/p>\n

Emory University School of Medicine<\/p>\n

Atlanta, USA<\/td>\n<\/tr>\n

5:45 to 6:15 PM<\/td>\nGenetic and Transcriptional Engineering of Primary Human Blood Cells<\/td>\nRasmus O. Bak<\/strong><\/p>\n

Aarhus University, Department of Biomedicine,<\/p>\n

Aarhus, Denmark<\/td>\n<\/tr>\n

6:15 to 6:45 PM<\/td>\nInnovative Non-Genotoxic Cell and Gene Therapies for Fanconi Anemia<\/td>\nAgnieszka Czechowicz<\/strong><\/p>\n

Stanford University School of Medicine, Dept of Pediatrics Div. of Stem Cell Transplantation and Regenerative Medicine, Stanford, US<\/td>\n<\/tr>\n

KEYNOTE ADDRESS<\/strong><\/p>\n

Chair: <\/strong>Alok Srivastava<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
6:45 to 7:45 PM<\/td>\nThe Concept of Innovation and Orchestration: Translating Engineered Cellular Therapies from Bench to Bedside<\/td>\nKhalid Shah<\/strong><\/p>\n

Center for Stem Cell and Translational Immunotherapy, Brigham and Women’s Hospital and Harvard Stem Cell Institute, Cambridge, USA<\/td>\n<\/tr>\n

End of Day-<\/strong>1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/strong><\/p>\n

DAY-2: Friday,\u00a0 <\/strong>2nd <\/strong>\u00a0August, 202<\/strong>4<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Session-<\/strong>4<\/strong>: <\/strong>INDUSTRY UPDATES<\/strong><\/p>\n

\u00a0Chair: <\/strong>Praveen Kumar Vemula<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
12:00\u00a0 to 12:20 PM<\/td>\nNon-Viral Chimeric Antigen Receptor (CAR) T Cells going Viral: Process Studies from Stanford Center for Cancer Cell<\/td>\nVimal Keerthi<\/strong><\/p>\n

Stanford University School of Medicine,<\/p>\n

California, US<\/td>\n<\/tr>\n

12: 20\u00a0 to 12:40 PM<\/td>\nWriting the Future of Biologics with an Integrated Offering of Immunization, Libraries, and Machine Learning<\/td>\nJay Yang<\/strong><\/p>\n

Twist Bioscience, San Francisco,<\/p>\n

California, US<\/td>\n<\/tr>\n

12:40\u00a0 to 1:00 PM<\/td>\nTransforming Viral Vector Production: Enhancing Efficiency and Scale-Up with OmniBRx\u2019s Dynamic Bed Reactor Technology<\/td>\n\u00a0Ravindra Patel<\/strong><\/p>\n

OmniBRx Biotechnologies Pvt Ltd.<\/p>\n

Ahmedabad, Gujarat, India<\/td>\n<\/tr>\n

1:00 \u00a0to 2:00 PM<\/td>\nLunch Break<\/strong><\/td>\n<\/tr>\n
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/strong>\u00a0\u00a0Session-5: APPLICATION OF IPSC TECHHNOLOGY<\/strong><\/p>\n

Chair: Maneesha S. Inamdar<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
2:00 to 2:30 PM<\/td>\nChallenges for the development of pluripotent stem cell based therapies and the role of international standards.<\/td>\nGlyn Stacey<\/strong><\/p>\n

International Stem Cell Banking Initiative, Barley, UK<\/td>\n<\/tr>\n

2:30 to 3:00 PM<\/td>\nDeveloping iPSC-derived RPE cell replacement therapy for the treatment of AMD<\/td>\nRajarshi Pal<\/strong><\/p>\n

Eyestem Research, Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India<\/td>\n<\/tr>\n

3:00 to 3:30 PM<\/strong><\/td>\niPSC based disease modelling<\/td>\nR V Shaji
\n<\/strong>Centre for Stem Cell Research (a unit of inStem, Bengaluru) and CMC, Vellore, India<\/td>\n<\/tr>\n
3:30 to 3:45 PM<\/strong><\/td>\nBreak<\/strong><\/td>\n<\/tr>\n
\u00a0Session-6: GENE THERAPY<\/strong><\/p>\n

Chair: Ullas Kolthur-Seetharam<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
3:45 to 4.15 PM<\/td>\nNew insights into the use of gamma delta T cells to treat childhood cancers<\/td>\nH. Trent Spencer<\/strong><\/p>\n

Emory University School of Medicine,<\/p>\n

Atlanta, USA<\/td>\n<\/tr>\n

4:15 to 4:45 PM<\/td>\nDevelopment of genome-modified generation ZZ (GenZZ) single-stranded AAV vectors with improved transgene expression<\/td>\nArun Srivastava<\/strong><\/p>\n

University of Florida, Florida, USA<\/td>\n<\/tr>\n

4:45 to 5:15 PM<\/td>\nPreclinical development of gene therapy for Diamond-Blackfan anemia<\/td>\nSenthil Bhoopalan\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n

St. Jude Children’s Research Hospital,<\/p>\n

Memphis, USA<\/td>\n<\/tr>\n

5:15 to 6:00 PM<\/td>\nPoster presentation<\/strong> and <\/strong>Industry <\/strong>Exhibition <\/strong><\/td>\n<\/tr>\n
Session-7: Challenges And Opportunities In Gene Therapy<\/strong><\/p>\n

Chair: <\/strong>RV Shaji<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
6:00 to 6:30 PM<\/td>\nDevelopment of pathophysiologicallyrelevant models of \u03b2-hemoglobinopahtues for therapeutic studies<\/td>\nSivaprakash Ramalingam<\/strong><\/p>\n

CSIR\u2013Institute Of Genomics And Integrative Biology (CSIR\u2013IGIB), New Delhi, India<\/td>\n<\/tr>\n

6:30 to 7:00 PM<\/td>\nCAR T-cell induced T-cell malignancies<\/td>\n\n

Nirali Shah<\/h2>\n

Center for Cancer Research, National Cancer Institute, Maryland, US<\/h2>\n<\/td>\n<\/tr>\n

7:00 to 7:30 PM<\/td>\nGenome Editing of HSCs to Develop Stem Cell Based Therapies<\/td>\nMatthew Porteus<\/strong><\/p>\n

Stanford School of Medicine,<\/p>\n

California, USA<\/td>\n<\/tr>\n

KEY NOTE ADDRESS<\/strong><\/p>\n

Chair: Sanjay Singh<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
7:30 to 8:30 PM<\/td>\nGene therapy for Haemophilia in India – The beginning of a new era<\/td>\nAlok Srivastava<\/strong><\/p>\n

Christian Medical College<\/p>\n

and Centre for Stem Cell Research Vellore,\u00a0India<\/td>\n<\/tr>\n

End of Day-2<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

DAY-3: Saturday,\u00a0 3rd\u00a0 August, 2024<\/strong><\/p>\n\n\n\n\n\n\n\n
Session-<\/strong>8<\/strong>: <\/strong>INDUSTRY UPDATES<\/strong><\/td>\n<\/tr>\n
India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
12:20\u00a0 to 12:40 PM<\/td>\nAutologous CAR-T Cell Therapy Manufacturing Solution<\/td>\nPankaj Salvi<\/strong><\/p>\n

Cytiva, Marlborough, US<\/td>\n<\/tr>\n

12:40\u00a0 to 01:00 PM<\/td>\nThermo Fisher Scientific: Cell & Gene Therapy capabilities overview<\/td>\nUchenna Waturuocha<\/strong><\/p>\n

Thermo Fisher Scientific,<\/p>\n

Mumbai, India<\/td>\n<\/tr>\n

01:00 to 02:00 PM<\/td>\nLunch <\/strong>Break<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Session-9: NON-VIRAL VECTOR BASED GENE THERAPY<\/strong><\/p>\n

Chair: N. Madhusudhana Rao<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
2:00 to 2:30 PM<\/td>\nEnhancing Natural killer cells proliferation and cytotoxicity using Imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNA<\/td>\nChantal Pichon<\/strong><\/p>\n

INSERM and University of Orl\u00e9ans, Orl\u00e9ans, France: Institut Universitaire de France, Paris<\/td>\n<\/tr>\n

\n

2:30 to 3:00 PM<\/td>\n

MSC Extracellular Vesicles: Navigating Regenerative Medicine\u2019s Therapeutic Landscape<\/td>\nSujata Mohanty<\/strong><\/p>\n

All India Institute of Medical Sciences<\/p>\n

New Delhi, India<\/td>\n<\/tr>\n

3:00 to 3:30 PM<\/strong><\/td>\nSugar-alcohol modified poly(beta-amino) ester nanoparticles for gene delivery to the brain<\/td>\nMunia Ganguli<\/strong><\/p>\n

Institute of Genomics and Integrative Biology<\/p>\n

(CSIR-IGIB), New Delhi, India<\/td>\n<\/tr>\n

3:30 to 3:45 PM<\/td>\nBreak<\/strong><\/td>\n<\/tr>\n
3:45 to 4:30 PM<\/td>\nPoster presentation<\/strong> and <\/strong>Industry <\/strong>Exhibition <\/strong><\/td>\n<\/tr>\n
Session-10: GENE EDITING<\/strong><\/p>\n

Chair: Sanjeev Galande<\/strong><\/td>\n<\/tr>\n

India Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
4:30 to 5:00 PM<\/td>\nGenome editing strategies for treating sickle cell disease<\/td>\nThiyagaraj Mayuranathan<\/strong><\/p>\n

Centre for Stem Cell Research (A unit of inStem, Bengaluru), Vellore, India<\/td>\n<\/tr>\n

5:00 to 5:30 PM<\/td>\nEpitope Editing for an Immunotherapy \u201cStealth\u201d Hematopoiesis<\/td>\nPietro Genovese<\/strong><\/p>\n

Harvard Medical School,<\/p>\n

Boston, USA<\/td>\n<\/tr>\n

5:30 to 6:00 PM<\/td>\nNext-generation gene editing of human hematopoietic stem cells: from research to clinical translation<\/td>\nSamuele Ferrari<\/strong><\/p>\n

San Raffaele Telethon Institute for Gene Therapy<\/p>\n

(SR-Tiget), Milan, Italy<\/td>\n<\/tr>\n

Session-11: IMMUNE CELL THERAPY<\/strong><\/p>\n

Chair: Amit Awasthi<\/strong><\/td>\n<\/tr>\n

\u00a0<\/strong><\/p>\n

India Time<\/strong><\/td>\n

Title<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
6:00 to 6:30 PM<\/td>\nCART Therapy in Pediatric Acute Lymphoblastic Leukemia<\/td>\nSunil Bhat<\/strong><\/p>\n

Mazumdar Shaw Medical Centre, Narayana Health City, Bangalore, India<\/td>\n<\/tr>\n

6:30 to 7:00 PM<\/td>\nDevelopment of CAR-T cell products with non-viral vector system<\/td>\nYoshiyuki Takahashi<\/strong><\/p>\n

Nagoya University Graduate School of Medicine,<\/p>\n

Nagoya, Japan<\/td>\n<\/tr>\n

7:00 to 7:30 PM<\/td>\nGenetic manipulation of NK cells for enhanced immunotherapy<\/td>\n\u00a0Rizwan <\/strong>Romee<\/strong><\/p>\n

Harvard Medical School, Dana Farber Cancer Institute, Boston, USA<\/td>\n<\/tr>\n

CONCLUDING REMARK<\/strong><\/td>\n<\/tr>\n
End of Day-3<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

9TH ANNUAL SYMPOSIUM ON CELL AND GENE THERAPY 1st \u00a0to 3rd\u00a0 August, 2024 PROGRAMME SCHEDULE DAY-1: Thursday, 1st \u00a0August, 2024 1:00 to 1:05 PM 1:05 to 1:20 PM 1:20 to 1:25 PM 1:25 to 1:30 PM \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Prayer by Chaplain \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Welcome remarks: Director, CMC \/ Director, InStem \/ Principal, CMC \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Remarks by\u00a0 Secretary, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template\/fullwidth.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/2747"}],"collection":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/comments?post=2747"}],"version-history":[{"count":1,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/2747\/revisions"}],"predecessor-version":[{"id":2748,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/2747\/revisions\/2748"}],"wp:attachment":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/media?parent=2747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}